Education
About Us
Working with TipRanks
Follow Us
Claritev (CTEV)
NYSE:CTEV
CTEV Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.80 - $45.63
Previous CloseN/A
VolumeN/A
Average Volume (3M)138.77K
Market Cap
$716.30M
Enterprise Value$33.84B
Total Cash (Recent Filing)$23.13M
Total Debt (Recent Filing)$4.63B
Price to Earnings (P/E)―
Beta1.77
Next Earnings
Jul 31, 2025EPS Estimate
-1.45Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.38
Shares Outstanding16,436,369
10 Day Avg. Volume221,132
30 Day Avg. Volume138,774
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)16.41
Price to Sales (P/S)0.00
P/FCF Ratio103.99
Enterprise Value/Market Cap47.24
Enterprise Value/Revenue9.01
Enterprise Value/Gross Profit49.21
Enterprise Value/Ebitda-11.87
Forecast
1Y Price Target
$34.50Price Target Upside-20.84% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Claritev News
Ownership Overview
13.64% Insiders
28.49% Mutual Funds
0.11% Other Institutional Investors
54.25% Public Companies and Individual Investors
CTEV FAQ
What was Claritev’s price range in the past 12 months?
Claritev lowest stock price was $4.80 and its highest was $45.63 in the past 12 months.
What is Claritev’s market cap?
Claritev’s market cap is $716.30M.
When is Claritev’s upcoming earnings report date?
Claritev’s upcoming earnings report date is Jul 31, 2025 which is in 30 days.
How were Claritev’s earnings last quarter?
Claritev released its earnings results on May 08, 2025. The company reported -$4.38 earnings per share for the quarter, missing the consensus estimate of -$3.123 by -$1.257.
Is Claritev overvalued?
According to Wall Street analysts Claritev’s price is currently Overvalued.
Does Claritev pay dividends?
Claritev does not currently pay dividends.
What is Claritev’s EPS estimate?
Claritev’s EPS estimate is -1.45.
How many shares outstanding does Claritev have?
Claritev has 16,436,369 shares outstanding.
What happened to Claritev’s price movement after its last earnings report?
Claritev reported an EPS of -$4.38 in its last earnings report, missing expectations of -$3.123. Following the earnings report the stock price went up 1.649%.
Which hedge fund is a major shareholder of Claritev?
Currently, no hedge funds are holding shares in CTEV
Claritev Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$34.50 (-20.84% Downside)
$34.50 (-20.84% Downside)
Hedge Fund Trend
Increased
By 987.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $1.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.4%
Last 30 Days ▲ 17.1%
Last 30 Days ▲ 17.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
158.66%
12-Months-Change
Fundamentals
Return on Equity
-198.69%
Trailing 12-Months
Asset Growth
-20.14%
Trailing 12-Months
Company Description
Claritev
Claritev (CTEV) is a technology company specializing in advanced data analytics and artificial intelligence solutions. Operating within the tech sector, Claritev develops software platforms that enable businesses to optimize their data management, derive actionable insights, and enhance decision-making processes across various industries.
CTEV Company Deck
CTEV Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant strategic advancements, including successful debt refinancing, major contract wins, and product launches, which are offset by challenges such as a decline in revenue and dependence on a single client's performance. Overall, the company is optimistic about its future growth and transformation efforts, although it faces headwinds in its core business segments.Read More>CTEV Stock 12 Month Forecast
Average Price Target
$34.50
▼(-20.84%Downside)
Technical Analysis
Heron Therapeutics
―
Benitec Biopharma
―
Tectonic Therapeutic
―
Eton Pharmaceuticals
―
AbSci
―